Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Indoleacetyl glutamine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003032 AN004971 Effects of Preanalytical Sample Collection and Handling on Comprehensive Metabolite Measurements in Human Urine Biospecimens Urine Human National Center for Advancing Translational Sciences Other
ST002909 AN004777 Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis Blood Human Melioidosis University of Washington Other
ST002829 AN004621 Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study Blood Human COVID-19 National Institutes of Health Other
ST002820 AN004596 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center Other
ST002819 AN004592 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center Other
ST002818 AN004588 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center Other
ST002498 AN004656 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine LC-MS
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham and Women's Hospital LC-MS
ST002089 AN003412 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health LC-MS
ST002088 AN003408 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health LC-MS
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center LC-MS
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center LC-MS
ST001827 AN002963 The pregnancy metabolome from a multi-ethnic pregnancy cohort Blood Human Icahn School of Medicine at Mount Sinai LC-MS
ST001749 AN002848 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin-Madison LC-MS
ST001639 AN002683 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health LC-MS
ST001517 AN002518 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) Blood Human Malaria New York University Abu Dhabi LC-MS
ST001516 AN002515 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) Blood Human Malaria New York University Abu Dhabi LC-MS
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan LC-MS
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan LC-MS
ST001400 AN002340 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria Blood Human Malaria New York University Abu Dhabi LC-MS
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology LC-MS
ST000899 AN001462 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center LC-MS
ST000241 AN000373 Cyclobutene- and cyclobutane-functionalized fatty acids as novel biochemical probes of structure and function in HepG2 cells Cultured cells Human University of Nebraska-Lincoln LC-MS
  logo